Slide 1 Identifying the key events behind Niemann-Pick type C1 disease pathology, cholesterol (for once) is not a killer Emyr Lloyd-Evans Slide 2 Background of Niemann-Pick…

Slide 1 Basics of Lipid and Lipoprotein Metabolism John R. Guyton, M.D. Associate Professor of Medicine Duke University Durham, NC Slide 2 Lipid Structure HO Cholesterol…

Slide 1 Dyslipidemia: Updated Guidelines C atalino L. De La Cruz, Jr., MD, FACC Slide 2 Disclosures Nothing to disclose Slide 3 Definition Cholesterol is a fatty substance…

Step 3 Step 3 P-treatment: Drug Class Selection Step 3, choosing the P-treatment for dyslipidemia. It must be noted that more importantly, lifestyle modification must be…

Step 3 Step 3 P-treatment: Drug Class Selection Step 3, choosing the P-treatment for dyslipidemia. It must be noted that more importantly, lifestyle modification must be…

In patients with type 2 diabetes, are the clinical effects of TZDâs the same? The concept of Diabetes & CV risk: A lifetime risk challenge Vascular function as an early…

Slide 1 The concept of Diabetes & CV risk: A lifetime risk challenge Vascular function as an early sign of trouble: How can the inhibition of cholesterol absorption reduce…